A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions

Clinical trial NCT01701193 · COMPLETED

Trial details

NCT number: NCT01701193
Sponsor: Temple Therapeutics BV
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pelvic Adhesions

Start date: 2015-02-15
Primary completion: 2016-10-20
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.